Glovista Investments LLC decreased its holdings in Amgen Inc. (NASDAQ:AMGN – Get Rating) by 0.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 7,062 shares of the medical research company’s stock after selling 47 shares during the quarter. Amgen makes up about 0.9% […]